A Reduction in anti-tuberculosis drug resistance after the implementation of the national "STOP TB"' program in Central Taiwan, 2003-2007

Japanese Journal of Infectious Diseases

Volumn 66, Issue 2, 2013, Pages 89-95

  Huang, Wei Chang ^a,b   Chen, Chao Hsien ^c   Huang, Chen Cheng ^d   Wu, Kun Ming ^e   Chiou, Chien Shun ^f   Lin, Chen Fu ^a   Chen, Jiann Hwa ^b   Shen, Gwan Han ^a,b,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d Department of Internal Medicine   (China)

^e Reference Medical Laboratory   (Taiwan)

^f CENTER FOR DISEASE CONTROL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTI TUBERCULOSIS DRUG RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DRUG RESISTANCE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HEALTH PROGRAM; HUMAN; INCIDENCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TAIWAN; TREATMENT OUTCOME; TUBERCULOSIS CONTROL;

ANTITUBERCULAR AGENTS; COMMUNICABLE DISEASE CONTROL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HEALTH POLICY; HUMANS; INCIDENCE; MALE; MYCOBACTERIUM TUBERCULOSIS; TAIWAN; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84875301459     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.66.89     Document Type: Article

References (26)

1. Young, D.-B., Perkins, M.-D., Duncan, K., et al. (2008): Confronting the scientific obstacles to global control of tuberculosis. J. Clin. Invest., 118, 1255-1265.
2. Hsueh, P.-R., Liu, Y.-C., So, J., et al. (2006): Mycobacterium tuberculosis in Taiwan. J. Infect., 52, 77-85.
3. Mori, T. (2007): MDR-TB-its characteristics and control in Asia-Pacific rim symposium in USJCMSP 10th international conference on emerging infectious diseases in the Pacific rim. Tuberculosis, 87 (Suppl. 1), S5-9.
4. Lancet Editorial (2006): XDR-TB-a global threat. Lancet, 368, 964.
5. Mlambo, C.-K., Warren, R.-M., Poswa, X., et al. (2008): Genotypic diversity of extensively drug-resistant tuberculosis (XDRTB) in South Africa. Int. J. Tuberc. Lung Dis., 12, 99-104.
6. Blaas, S.-H., Mutterlein, R., Weig, J., et al. (2008): Extensively drug-resistant tuberculosis in a high income country: a report of four unrelated cases. BMC Infect. Dis., 8, 60.
7. Pillay, M. and Sturm, A.-W. (2007): Evolution of the extensively drug-resistant 15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Clin. Infect. Dis., 45, 1409-1414.
8. Kim, H.-R., Hwang, S.-S., Kim, H.-J., et al. (2007): Impact of extensive drug resistance on treatment outcomes in non-HIVinfected patients with multi-drug-resistant tuberculosis. Clin. Infect. Dis., 45, 1290-1295.
9. Yu, M.-C., Wu, M.-H. and Jou, R. (2008): Extensively drugresistant tuberculosis, Taiwan. Emerg. Infect. Dis., 14, 849-850.
10. Wang, P.-D. and Lin, R.-S. (2001): Drug-resistant tuberculosis in Taipei, 1996-1999. Am. J. Infect. Control, 29, 41-47.
11. Lu, P.-L., Lee, Y.-W., Peng, C.-F., et al. (2003): The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000. Int. J. Antimicrob. Agents, 21, 239-243.
12. Centers for Disease Control, Department of Health, Executive Yuan, Taiwan: Annual Report of Notifiable Infectious Diseases (Taiwan). Online at . Accessed 10 October 2011.
13. Su, W.-J., Feng, J.-Y., Huang, C.-C., et al. (2008): Increasing drug resistance of Mycobacterium tuberculosis isolates in a medical center in Northern Taiwan. J. Formos. Med. Assoc., 107, 259-264.
14. Witebsky, F.-G. and Kruczak-Filipov, P. (1996): Identification of mycobacteria by conventional methods. Clin. Lab. Med., 16, 569-601.
15. McCarter, Y.-S., Ratkiewicz, I.-N. and Robinson, A. (1998): Cord formation in BACTEC medium is a reliable, rapid method for presumptive identification of Mycobacterium tuberculosis complex. J. Clin. Microbiol., 36, 2769-2771.
16. Woods, G.-L. (2000): Susceptibility testing for mycobacteria. Clin. Infect. Dis., 31, 1209-1215.
17. Wang, J.-Y., Lee, L.-N., Lai, H.-C., et al. (2007): Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure. J. Antimicrob. Chemother., 59, 860-865.
18. Huang, T.-S., Kunin, C.-M., Lee, S.-J., et al. (2005): Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003. J. Antimicrob. Chemother., 56, 1058-1062.
19. Kontos, F., Petinaki, E., Nicolaou, S., et al. (2003): Multicenter evaluation of the fully automated Bactec MGIT 960 system for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide: comparison with the radiometric Bactec 460TB system. J. Microbiol. Methods, 55, 331-333.
20. Shah, N.-S., Pratt, R., Althomsons, S., et al. (2007): Extensively drug-resistant tuberculosis-United States, 1993-2006. Morbid. Mortal. Wkly. Rep., 56, 250-253.
21. Hsu, C.-B., Lo, H.-Y., Lee, C.-Y., et al. (2008): Preliminary evaluation of Taiwan's tuberculosis DOTS strategy. Taiwan Epidemiol. Bull., 24, 230-253.
22. Liaw, Y.-S., Hsueh, P.-R., Yu, C.-J., et al. (2004): Drug resistance pattern of Mycobacterium tuberculosis in a university hospital in Taiwan, 1998-2002. J. Formos. Med. Assoc., 103, 671-677.
23. Liu, C.-E., Chen, C.-H., Hsiao, J.-H., et al. (2004): Drug resistance of Mycobacterium tuberculosis complex in central Taiwan. J. Microbiol. Immunol. Infect., 37, 295-300.
24. Chen, Y.-T., Lee, J.-J., Chiang, C.-Y., et al. (2012): Effective interventions and decline of anti-tuberculosis drug resistance in Eastern Taiwan, 2004-2008. PLoS ONE, 7(2):e31531. Doi:10.1371/journal.pone.0031531.
25. Van Deun, A., Salim, A.-H., Daru, P., et al. (2004): Drug resistance monitoring: combined rates may be the best indicator of program performance. Int. J. Tuberc. Lung Dis., 8, 23-30.
26. Moonan, P.-K., Quitugua, T.-N., Pogoda, J.-M., et al. (2011): Does directly observed therapy (DOT) reduce drug resistant tuberculosis? BMC Public Health, 11, 19.